Vascular endothelial inflammatory markers

Vascular endothelial inflammatory markers are a heterogeneous group of proteins, including cell adhesion molecules and selectins, that mediate the interaction between the blood vessel wall and circulating leukocytes. Key members of this group include Intercellular Adhesion Molecule 1 (ICAM-1), Vascular Cell Adhesion Molecule 1 (VCAM-1), and E-selectin, which are upregulated in response to pro-inflammatory cytokines like TNF-alpha and IL-1 beta (Source: PubMed, PMID: 11594444). These markers play a fundamental role in the early stages of atherosclerosis by promoting the recruitment of monocytes and T-cells to the arterial intima (Source: StatPearls, NBK554410). Beyond cardiovascular disease, they are involved in the pathogenesis of sepsis, diabetes, and various autoimmune conditions where endothelial activation is a hallmark. Therapeutic intervention can occur through the use of statins, which exert pleiotropic effects to lower marker expression, or through targeted biologics like Crizanlizumab that inhibit specific selectins (Source: PubMed, PMID: 28199814; Source: PubMed, PMID: 16170329). Monitoring the levels of soluble forms of these markers in the plasma serves as a valuable clinical tool for assessing endothelial health and the efficacy of anti-inflammatory treatments. Because this term refers to a collective set of proteins rather than a single receptor or enzyme, it is categorized as a biomarker group rather than a specific therapeutic target.

Other names

Endothelial activation markersEndothelial dysfunction markersVascular adhesion moleculesEndothelial cell surface markers

Inhibition of transcriptional expression (e.g., via NF-kappaB pathway modulation) or direct blockade of protein-protein interactions between endothelial markers and leukocyte ligands.